|
|
|
|
|
|
|
||||
| Home Help Feedback Subscriptions Archive Search Table of Contents | ||||
Department of Zoology, University of Oxford, South Parks Road, Oxford OX1 3PS, UK
*Author for correspondence (e-mail: bass.hassan{at}zoo.ox.ac.uk)
Accepted July 5, 2001
The size of mammalian species involves the interaction of multiple genetic modifiers that control the timing and extent of growth mechanisms. Disruption of the paternal allele of the imprinted embryonic gene coding for insulin-like growth factor 2 (IGF2, Igf2+m/-p), results in viable mice that are 60% the weight of wild-type littermates. Differences in weight are first detected at embryonic day (E) 11, and the growth deficit is maintained throughout life. We report the mechanisms that account for this unusual phenotype. In order to quantify growth, we used novel methods to generate single cell suspensions of post-implantation mouse embryos. We were then able to quantify cell number, cell proliferation and cell death between E8.5 and E11.5 using flow cytometry. Determination of total embryo cell number also allowed us to time litters by a method other than by plugging. Wild-type and Igf2+m/-p embryos accumulated similar total cell numbers up to E9.25, but cell number began to diverge by around E9.5, with significant differences by E11 (75% of wild type). A relative increase in pyknotic nuclei, sub-GI cytometry counts and caspase activity, all indicative of cell death, occurred in Igf2+m/-p embryos at E9.25, reverting to wild-type levels by E9.75. This was followed at E9.75 by a significant reduction in the proportion of cells in S phase, quantified by S-phase cytometry counts and BrdU labelling. No significant differences in cell size were detected. We conclude that the majority of the cell number differences between wild-type and Igf2+m/-p mice can be accounted for by modification of cell survival and proliferation during the period (E9 to E10) of post-implantation development.
Key words: Insulin-like growth factor 2, Embryo cell number, Cell survival, Cell proliferation, Embryonic growth, Mouse
This article has been cited by other articles:
|
|
 |
|
  D. Brown, B. D. Yu, N. Joza, P. Benit, J. Meneses, M. Firpo, P. Rustin, J. M. Penninger, and G. R. Martin Loss of Aif function causes cell death in the mouse embryo, but the temporal progression of patterning is normal PNAS, June 27, 2006; 103(26): 9918 - 9923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Harper, J. L. Burns, E. J. Foulstone, M. Pignatelli, S. Zaina, and A. B. Hassan Soluble IGF2 Receptor Rescues ApcMin/+ Intestinal Adenoma Progression Induced by Igf2 Loss of Imprinting Cancer Res., February 15, 2006; 66(4): 1940 - 1948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. K Bale and C. A Conover Disruption of insulin-like growth factor-II imprinting during embryonic development rescues the dwarf phenotype of mice null for pregnancy-associated plasma protein-A J. Endocrinol., August 1, 2005; 186(2): 325 - 331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Wu, S. Ohsako, R. Ishimura, J. S. Suzuki, and C. Tohyama Exposure of Mouse Preimplantation Embryos to 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) Alters the Methylation Status of Imprinted Genes H19 and Igf2 Biol Reprod, June 1, 2004; 70(6): 1790 - 1797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Conover, L. K. Bale, M. T. Overgaard, E. W. Johnstone, U. H. Laursen, E.-M. Fuchtbauer, C. Oxvig, and J. van Deursen Metalloproteinase pregnancy-associated plasma protein A is a critical growth regulatory factor during fetal development Development, March 1, 2004; 131(5): 1187 - 1194. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Meilhac, R. G. Kelly, D. Rocancourt, S. Eloy-Trinquet, J.-F. Nicolas, and M. E. Buckingham A retrospective clonal analysis of the myocardium reveals two phases of clonal growth in the developing mouse heart Development, August 15, 2003; 130(16): 3877 - 3889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Bennett, T. E. Crew, J. M. W. Slack, and A. Ward Structural-proliferative units and organ growth: effects of insulin-like growth factor 2 on the growth of colon and skin Development, March 15, 2003; 130(6): 1079 - 1088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Hassan Keys to the Hidden Treasures of the Mannose 6-Phosphate/Insulin-Like Growth Factor 2 Receptor Am. J. Pathol., January 1, 2003; 162(1): 3 - 6. [Full Text] [PDF]
|
|
|
|
 |
|
 A. B. Hassan and V. M. Macaulay The insulin-like growth factor system as a therapeutic target in colorectal cancer Ann. Onc., March 1, 2002; 13(3): 349 - 356. [Abstract] [Full Text] [PDF]
|
|
